期刊文献+

乳腺癌肿块切除对腋窝淋巴结状态的影响 被引量:4

The influence of lumpectomy on the axillary lymph node status of breast cancer patients
原文传递
导出
摘要 目的探讨乳腺癌肿块切除对腋窝淋巴结状态的影响。方法回顾性分析河南省肿瘤医院2011年11月至2013年8月腋窝触诊阴性、行前哨淋巴结(SLN)活检的738例浸润性乳腺癌的临床资料。136例患者术前在外院行乳腺癌肿块切除术(肿块切除组),602例患者术前未行肿块切除术而是经穿刺活检证实(穿刺活检组),比较两组患者彩超下腋窝淋巴结状态和SLN阳性率的差异。结果738例患者中,444例(60.2%)患者彩超下腋窝淋巴结可见,其中肿块切除组和穿刺活检组分别为92例和352例,差异有统计学意义(P=0.048)。彩超下腋窝淋巴结可见患者中,肿块切除组和穿刺活检组患者腋窝最大淋巴结〉1cm者所占比例分别为58.7%(54/92)和52.8%(186/352),差异无统计学意义(P=0.316);腋窝最大淋巴结长径与短径比值〉2者所占比例分别为37.0%(34/92)和38.6%(136/352),差异无统计学意义(P=0.768)。肿块切除组和穿刺活检组患者的SLN阳性率分别为23.5%(32/136)和26.9%(162/602),差异无统计学意义(P=0.419)。肿块切除时间≤7d和〉7d患者腋窝可见淋巴结的发生率分别为71.1%(64/90)和60.9%(28/46),差异无统计学意义(P=0.227);SLN阳性率分别为28.9%(26/90)和13.0%(6/46),差异有统计学意义(P=0.039)。彩超可见腋窝淋巴结、腋窝最大淋巴结长径和长径与短径比值〈2与SLN阳性率均有关(均P〈0.05)。结论乳腺癌肿块切除术后,彩超下可见腋窝淋巴结的发生率更高。对于肿块切除至彩超检查时间较长的患者,即使彩超下可见腋窝淋巴结,其SLN阳性率也较低。 Objective To investigate the influence of lumpectomy on axillary lymph node status of breast cancer patients. Methods The clinical data of 738 invasive breast cancer patients with non-palpable axillary lymph node and sentinel lymph node (SLN) biopsy from November 2011 to August 2013 in Henan Provincial Cancer Hospital were collected and retrospectively analyzed. Among them, 136 patients underwent preoperative lumpectomy (lumpectomy group ) and 602 patients underwent puncture biopsy only (biopsy group). The difference of axillary lymph node status and positive ratio of SLN detected by color Doppler ultrasound were compared between these two groups. Results Among the 738 breast cancer patients, the axitlaly lymph nodes of 444 ( 60.2% ) cases could be detected by uhrasound. Among them, 92 cases belonged to lumpectomy group, significantly less than 352 cases of biopsy group (P=0.048). Among the patients with uhrasound-visible lymph nodes, the proportion of the biggest diameter of axillary lymph node 〉 1 cm of lumpectomy group or biopsy group was 58.7% (54/92) or 52.8% ( 186/352), respectively, without significant difference (P= 0.316). The proportion of patients with the ratio of long diameter to short diameter 〈2 of lumpectomy group or biopsy group was 37.0% (34/92) or 38.6% (136/352) , respectively, with marginal difference (P= 0.768). The positive rate of SLN of lumpectomy group or biopsy group was 23.5% (32/136) or 26.9% (162/602) , respectively, without significant difference ( P = 0.419). The incidence rate of the ultrasound visible axillary lymph nodes of patients whose postoperative time ≤ 7 days or 〉 7days was 71.1% (64/90) or 60.9% ( 8/46), respectively, without significant difference (P= 0.227). However, the positive rate of SLN of these two groups was 28.9% (26/90) and 13.0% (6/46), respectively, with significant difference (P = 0. 039 ). The number of ultrasound visible axillary lymph nodes, the biggest diameter of axillary lymph nodes and the ratio of the long diameter to short diameter 〈 2 were substantially correlated with the positive rate of SLN (P〈0.05). Conclusions The incidence rate of ultrasound visible axillary lymph node in the patients with lumpectomy is higher than that of patients with puncture biopsy only. The positive rate of SLN of the patients with a long postoperative time is lower than that of patients with a short postoperative time, even though the axillary lymph nodes are uhrasound visible.
作者 焦得闯 朱久俊 乔江华 王丽娜 马有钊 卢振铎 刘真真 Jiao Dechuang;Zhu Jiujun;Qiao Jianghua;Wang Lina;Ma Youzhao;Lu Zhenduo;Liu Zhenzhen(Department of Breast Surgery, Affiliated Cancer Hospital of Zhengzhou University (Henan Provincial Cancer Hospital), Zhengzhou 450008, Chin)
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2018年第4期284-287,共4页 Chinese Journal of Oncology
关键词 乳腺肿瘤 淋巴结 肿块切除 Breast neoplasms Lymph node Local lumpectomy
  • 相关文献

参考文献5

二级参考文献52

  • 1王雪鹃,林保和,杨志,欧阳涛,李金锋,徐冰,张岩,张梅颖.新型前哨淋巴结显像剂在乳腺癌中的初步应用[J].中华肿瘤杂志,2006,28(3):200-203. 被引量:7
  • 2李金锋,欧阳涛,王雪鹃,王天峰,解云涛,范照清,林宝和,杨志,林本耀.新型示踪剂^(99m)Tc-利妥昔用于原发性乳腺癌前哨淋巴结活检的初步研究[J].中华外科杂志,2006,44(9):600-602. 被引量:13
  • 3李颖嘉,张雪林,文戈.造影增强能量多普勒超声评价腋淋巴结阴性乳腺癌的预后[J].中华外科杂志,2007,45(13):877-880. 被引量:4
  • 4全国肿瘤登记中心.中国肿瘤登记工作指导手册[M].北京:中国协和医科大学出版社,2004.48-50.
  • 5赫捷,赵平,陈万青.2012年中国肿瘤登记年报[M].北京:军事医学科学出版社,2012.56-59.
  • 6Land SR, Koped JA, Julian TB, et al. Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: national surgical adjuvant breast and bowel project phase ]H protocol B-32. J Clin Oncol,2010,28 : 3929-3936.
  • 7Pepels MJ, Vestjens JHMJ, de Boer M, et al. Safety of avoiding routine use of axillary dissection in early stage breast cancer: a systematic review. Breast Cancer Res Treat,2011,125 : 301-313.
  • 8Veronesi U, Paganilli G, Viale G, et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol,2006,7: 983-990.
  • 9Veronesi U, Galimberti V, Pagamelli G, et al. Axillary metastases in breast cancer patients with negative sentinel nodes : a follow-up of 3548 cases. Eur J Cancer,2009,45: 1381-1388.
  • 10Wely B J, van den Wildenberg FJH, Gobardhan P, et al. Axillary recurrences after sentinel lymph node biopsy: a multicentre analysis and follow-up of sentinel lymph node negative breast cancer patients. Eur J Surg Oncol, 2012, 38: 925-931.

共引文献922

同被引文献54

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部